~~<i id='2C518814F6'><strike id='2C518814F6'><tt id='2C518814F6'><pre id='2C518814F6'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

entertainment

author：leisure time 2025-09-30 00:39:01 - browse：7742

The Food and Drug Administration said on Friday that it has some safety concerns about an experimental CRISPR-based treatment for sickle cell disease, citing the methods used by its makers to evaluate the risk of inadvertently making unwanted changes to patients’ DNA.

None of the concerns raised by the FDA on Friday, however, suggest the agency is reluctant to approve the treatment, called exa-cel, which is being developed by Vertex Pharmaceuticals and CRISPR Therapeutics.

Exa-cel, given as a one-time infusion, uses CRISPR genome-editing technology to patch up the genetic faults at the root of sickle cell disease.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

focus

explore

leisure time

focus

entertainment

Astudyfoundthat92percentoffoodpopularwitheatersdiningoutexceedthethresholdofcaloriesforanormalmeal.H

WSS

White House pharmacy plagued with problems, investigation finds

Humana’s losses in Medicare Advantage tank its stock

Judge in Trump's classified documents case questions use of out

It was time to plan for my old age. If only I could stop crying

Doctors are clamoring for more clarity on Paxlovid prescribing

Slovenia has suffered its worst

hotspot

entertainment

focus

At least 13 dead in Texas as scorching temps continue

Mexico finds 491 migrants being held at vacant lot, almost all are from Guatemala

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Kansas bar where gunfire wounded 9 last month closes permanently

Guidelines to prevent youth baseball injuries need more muscle

Sage considers ways to reduce costs following FDA rejection

Supreme Court strikes down use of affirmative action

Syphilis numbers in the United States reach record heights

Tori Bowie and the unacceptable rates of Black maternal death

Readout Newsletter: Vertex, Pfizer, Kura, and other biotech news

explore

Trump used to be more articulate. What could explain the change?

The Affordable Care Act has saved billions in health care costs

Judge in Trump's classified documents case questions use of out

Feed a cold, starve a fever? Here’s what science says

Pancreatic cancer early detection could be helped by AI

Syphilis numbers in the United States reach record heights

explore

leisure time

focus

entertainment